1. The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
   Dexin Shen et al, 2021, Cancer Cell International CrossRef
2. A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers
   Zi Liu et al, 2022, Journal of Biological Chemistry CrossRef
3. CDCA3 exhibits a role in promoting the progression of ovarian cancer
   Shan Gong et al, 2022, Tissue and Cell CrossRef
4. Role of cell division cycle-associated proteins in regulating cell cycle and promoting tumor progression
   Zhaoyu Wang et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
5. Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells
   Fei Ma et al, 2020, PLOS ONE CrossRef
6. MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2
   Hui Yu et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
7. Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma
   Sarmad Al-Marsoummi et al, 2020, Cancers CrossRef
8. Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells
   Maria T. Löblein et al, 2021, International Journal of Molecular Sciences CrossRef
9. Genetic screening for anticancer genes highlights FBLN5 as a synthetic lethal partner of MYC
   Motasim Masood et al, 2023, Cell Communication and Signaling CrossRef
10. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma
    Jungang Chen et al, 2020, Blood CrossRef
11. Circ_0001421 facilitates glycolysis and lung cancer development by regulating miR-4677-3p/CDCA3
    Koudong Zhang et al, 2020, Diagnostic Pathology CrossRef
12. Novel c-Myc–Targeting Compound N, N-Bis (5-Ethyl-2-Hydroxybenzyl) Methylamine for Mediated c-Myc Ubiquitin-Proteasomal Degradation in Lung Cancer Cells
    Nicharat Sriratanasak et al, 2020, Molecular Pharmacology CrossRef
13. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis
    Dongwei Dou et al, 2020, Cancer Cell International CrossRef
14. Analysis and verification of N6-methyladenosine-modified genes as novel biomarkers for clear cell renal cell carcinoma
    Zhenyu Yang et al, 2021, Bioengineered CrossRef
15. CDCA3 promotes the proliferation and migration of hypopharyngeal squamous cell carcinoma cells by activating the Akt/mTOR pathway
    Junfu Wu et al, 2023, Biotechnology and Genetic Engineering Reviews CrossRef
16. CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
    Jean-Philippe Guégan et al, 2021, iScience CrossRef
17. Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha
    Yuqing Wang et al, 2021, Frontiers in Oncology CrossRef
18. Investigation of the Relationship between CMYC Gene Polymorphisms and Glioma Susceptibility in Chinese Children
    Susu Lou et al, 2021, Cancer Investigation CrossRef
19. Aberrant expression of KDM1A inhibits ferroptosis of lung cancer cells through up-regulating c-Myc
    Can Lu et al, 2022, Scientific Reports CrossRef
20. LncRNA landscape and associated ceRNA network in placental villus of unexplained recurrent spontaneous abortion
    Minyue Tang et al, 2023, Reproductive Biology and Endocrinology CrossRef